1 / 63

Sexually Transmitted Disease (STD) Surveillance Report, 2009

Sexually Transmitted Disease (STD) Surveillance Report, 2009. Minnesota Department of Health STD Surveillance System. www.health.state.mn.us/std. Introduction.

nili
Download Presentation

Sexually Transmitted Disease (STD) Surveillance Report, 2009

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Sexually Transmitted Disease (STD) Surveillance Report, 2009 Minnesota Department of Health STD Surveillance System www.health.state.mn.us/std

  2. Introduction • Under Minnesota law, physicians and laboratories must report all laboratory-confirmed cases of chlamydia, gonorrhea, syphilis, and chancroid to the Minnesota Department of Health (MDH) within one working day. • The MDH does not maintain statistics for other, non-reportable STDs (ex: herpes, HPV/genital warts). • This slide set describes trends in reportable STDs in Minnesota by person, place, and time. • Analyses exclude cases reported from federal and private prisons. STDs in Minnesota: Annual Review

  3. Introduction • STD surveillance is the systematic collection of data from cases for the purpose of monitoring the frequency and distribution of STDs in a given population. • STD surveillance data are used to detect problems, prioritize resources, develop and target interventions, and evaluate the effectiveness of interventions. STDs in Minnesota: Annual Review

  4. Interpreting STD Surveillance Data • Factors that impact the completeness and accuracy of STD data include: • Level of STD screening by healthcare providers • Individual test-seeking behavior • Sensitivity of diagnostic tests • Compliance with case reporting • Completeness of case reporting • Timeliness of case reporting • Increases and decreases in STD rates can be due to actual changes in disease occurrence and/or changes in one or more of the above factors. STDs in Minnesota: Annual Review

  5. Interpreting STD Surveillance Data • The surveillance system only includes cases diagnosed in conjunction with a positive laboratory test. Cases diagnosed solely on symptoms are not counted. • Surveillance data represent cases of infection, not individuals. A person with multiple infections in a given year will be counted more than once. • Caution is warranted when interpreting changes in STD numbers that can seem disproportionately large when the number of cases is small.

  6. National Context STDs in Minnesota: Annual Review

  7. United States: State-Specific Chlamydia Rates, 2008(National Rate = 401.3 per 100,000) SOURCE:Centers for Disease Control & Prevention, Division of STD Prevention. 2007 Surveillance Slides.

  8. United States: State-Specific Gonorrhea Rates, 2008(National Rate = 111.6 per 100,000) STDs in Minnesota: Annual Review SOURCE:Centers for Disease Control & Prevention, Division of STD Prevention. 2008 Surveillance Slides.

  9. United States: State-Specific P&S Syphilis Rates, 2008(National Rate = 4.5 per 100,000) STDs in Minnesota: Annual Review SOURCE:Centers for Disease Control & Prevention, Division of STD Prevention. 2008 Surveillance Slides.

  10. Overview of STDs in Minnesota STDs in Minnesota: Annual Review

  11. STDs in MinnesotaRate per 100,000 by Year of Diagnosis, 1999-2009 * P&S = Primary and Secondary.

  12. STDs in Minnesota:Number of Cases Reported in 2009 • Total of 16,702 STD cases reported to MDH in 2009: • 14,186 Chlamydia cases • 2,302 Gonorrhea cases • 214 Syphilis cases (all stages) • 0 Chancroid cases

  13. CHLAMYDIA STDs in Minnesota: Annual Review

  14. Chlamydia Infections by Residence at Diagnosis Minnesota, 2009 Suburban = Seven-county metro area including Anoka, Carver, Dakota, Hennepin (excluding Minneapolis), Ramsey (excluding St. Paul), Scott, and Washington counties. Greater MN = All other Minnesota counties outside the seven-county metro area.

  15. Chlamydia Rates by GenderMinnesota, 1999-2009

  16. Chlamydia Rates by AgeMinnesota, 1999-2009

  17. Age-Specific Chlamydia Rates by Gender Minnesota, 2009

  18. Chlamydia Rates by Race/Ethnicity Minnesota, 1999-2009 * Persons of Hispanic ethnicity can be of any race.

  19. Chlamydia Rates by Race/Ethnicity Minnesota, 1999-2009 * Persons of Hispanic ethnicity can be of any race.

  20. GONORRHEA STDs in Minnesota: Annual Review

  21. Gonorrhea Infections in Minnesotaby Residence at Diagnosis, 2009 Suburban = Seven-county metro area including Anoka, Carver, Dakota, Hennepin (excluding Minneapolis), Ramsey (excluding St. Paul), Scott, and Washington counties. Greater MN = All other Minnesota counties outside the seven-county metro area.

  22. Gonorrhea Rates by GenderMinnesota, 1999-2009

  23. Gonorrhea Rates by AgeMinnesota, 1999-2009

  24. Age-Specific Gonorrhea Rates by GenderMinnesota, 2009

  25. Gonorrhea Rates by Race/Ethnicity Minnesota, 1999-2009 * Persons of Hispanic ethnicity can be of any race.

  26. Gonorrhea Rates by Race/Ethnicity Minnesota, 1999-2009 * Persons of Hispanic ethnicity can be of any race.

  27. Quinolone-Resistant Neisseria gonorrhoeaein Minnesota • MDH routinely tracked fluoroquinolone resistance in gonorrhea isolates from 1999 – 2008 through the Gonococcal Isolate Surveillance Program (GISP) and continues limited resistance testing. • Resistance to ciprofloxacin increased from 0% of isolates among MSM in 1999 to a peak of 28% in 2007. The proportion then decreased in 2008 to 15%. Among heterosexuals, ciprofloxacin resistance increased from 0% of isolates in 1999 to 5% in 2008. • As of April 12, 2007 fluoroquinolones were no longer recommended for the treatment of gonorrhea†. †Centers for Disease Control and Prevention.[Update to CDC’s Sexually Transmitted Diseases Treatment Guidelines, 2006: Fluoroquinolones No Longer Recommended for Treatment of Gonococcal Infections]. MMWR 2007;56:[332-336].

  28. SYPHILIS STDs in Minnesota: Annual Review

  29. Syphilis Rates by Stage of Diagnosis Minnesota, 1999-2009 * P&S = Primary and Secondary

  30. Primary & Secondary Syphilis Infections in Minnesota by Residence at Diagnosis, 2009 Suburban = Seven-county metro area including Anoka, Carver, Dakota, Hennepin (excluding Minneapolis), Ramsey (excluding St. Paul), Scott, and Washington counties. Greater MN = All other Minnesota counties outside the seven-county metro area.

  31. Primary & Secondary Syphilis Rates by GenderMinnesota, 1999-2009

  32. Primary & Secondary Syphilis Rates by AgeMinnesota, 1999-2009

  33. Age-Specific Primary & Secondary SyphilisRates by Gender, Minnesota, 2009 *0 primary/secondary female syphilis cases were reported in 2009.

  34. Primary & Secondary Syphilis Cases by RaceMinnesota, 2009 *Includes persons reported with more than one race

  35. Primary & Secondary Syphilis Rates by Race/EthnicityMinnesota, 1999-2009 * Persons of Hispanic ethnicity can be of any race.

  36. CHLAMYDIA AND GONORRHEA AMONGADOLESCENTS & YOUNG ADULTS (15-19 year olds) (20-24 year olds) STDs in Minnesota: Annual Review

  37. Chlamydia Disproportionately Impacts Youth

  38. Gonorrhea Disproportionately Impacts Youth

  39. Characteristics of Adolescents & Young Adults†Diagnosed With Chlamydia or Gonorrhea in 2009

  40. Characteristics of Adolescents & Young Adults† Diagnosed With Chlamydia or Gonorrhea in 2009 Suburban = Seven-county metro area including Anoka, Carver, Dakota, Hennepin (excluding Minneapolis), Ramsey (excluding St. Paul), Scott, and Washington counties. Greater MN = All other Minnesota counties outside the seven-county metro area. † Adolescents defined as 15-19 year-olds; Young Adults defined as 20-24 year-olds.

  41. Chlamydia Rates Among Adolescents & Young Adults†by Gender in Minnesota, 1999-2009 Rate=Cases per 100,000 persons based on 2000 U.S. Census counts. † Adolescents defined as 15-19 year-olds; Young Adults defined as 20-24 year-olds.

  42. Chlamydia — Positivity Rates by Age and Gender MIPP† Clinics, 2002-2009 † The Minnesota Infertility Prevention Project (MIPP) is a project funded by the CDC to provide STD testing and treatment to uninsured men and women ages 15-24. Participating clinics include STD, family planning, adolescent, and community clinics.

  43. Chlamydia Cases Among Adolescents and Young Adults† by Gender and Race, Minnesota, 2009 † Adolescents defined as 15-19 year-olds; Young Adults defined as 20-24 year-olds.

  44. Chlamydia Rate Among Adolescents and Young Adults† by Race, Minnesota, 2009 Rate=Cases per 100,000 persons based on 2000 U.S. Census counts. † Adolescents defined as 15-19 year-olds; Young Adults defined as 20-24 year-olds.

  45. Chlamydia — Positivity Rates Among 15-24 Year-olds by Race MIPP† Clinics, 2002-2009 † The Minnesota Infertility Prevention Project (MIPP) is a project funded by the CDC to provide STD testing and treatment to uninsured men and women ages 15-24. Participating clinics include STD, family planning, adolescent, and community clinics.

  46. Gonorrhea Rates Among Adolescents & Young Adults†by Gender in Minnesota, 1999-2009 Rate=Cases per 100,000 persons based on 2000 U.S. Census counts. † Adolescents defined as 15-19 year-olds; Young Adults defined as 20-24 year-olds.

  47. Gonorrhea — Positivity Rates by Age and Gender MIPP† Clinics,1999-2009

More Related